谢晶日辨治慢性萎缩性胃炎经验
Xie Jingri’s Experience in Treating Chronic Atrophic Gastritis
DOI: 10.12677/jcpm.2026.54225, PDF,   
作者: 徐懿杨*:黑龙江中医药大学研究生院,黑龙江 哈尔滨;梁国英#:黑龙江中医药大学附属第一医院消化一科,黑龙江 哈尔滨
关键词: 谢晶日慢性萎缩性胃炎痰瘀伏络治中焦如衡名医经验 Xie Jingri Chronic Atrophic Gastritis Phlegm-Stasis Obstructing Collaterals Balancing the Middle Burner Famous Doctor’s Experience
摘要: 慢性萎缩性胃炎(Chronic Atrophic Gastritis, CAG)是以胃黏膜固有腺体减少为主要病理特征的慢性胃病,可伴肠上皮化生及上皮内瘤变,属于胃癌防治链条中的重要环节。谢晶日教授长期从事脾胃病临床与研究,认为本病以脾胃虚弱为本,肝失疏泄、中焦升降失司为关键环节,痰、湿、瘀、热、毒互结胃络为病机演变之要。其辨治强调“治中焦如衡”,重视因机立法、药对相伍与病理分层,在调气机、健脾胃、抑酸降逆、通腑化滞、化瘀消积、清热解毒诸法之间动态取舍。对于病程较久、肠上皮化生或低级别上皮内瘤变倾向者,尤重“痰瘀伏络、瘀久成毒”的病势判断,主张在顾护脾胃的前提下适时介入化瘀解毒之法,以延缓病理进展。本文结合谢晶日教授相关经验文献、近年来慢性萎缩性胃炎临床研究与基础研究进展,对其病机认识、辨治思路、用药特点及学术价值进行系统整理,以期为名医经验传承与该病临床防治提供参考。
Abstract: Chronic atrophic gastritis (CAG) is a chronic gastric disorder characterized by the loss of intrinsic glands and may be accompanied by intestinal metaplasia or intraepithelial neoplasia, representing an important stage in gastric cancer prevention. Professor XIE Jingri holds that the disease is rooted in deficiency of the spleen and stomach, with impaired liver regulation and disordered ascending-descending movement of the middle burner as the pivotal mechanism, while phlegm, dampness, blood stasis, heat and toxin lodged in the gastric collaterals constitute the key pathological evolution. His treatment emphasizes “balancing the middle burner”, and stresses therapeutic decisions based on mechanism differentiation, herb-pair application and pathological stratification. In clinical practice, he dynamically combines regulation of qi movement, strengthening of the spleen and stomach, acid suppression and downbearing, bowel unblocking, stasis-resolving, mass-dissipating and detoxifying methods. For patients with prolonged disease, intestinal metaplasia or a tendency toward low-grade intraepithelial neoplasia, he particularly values the judgment of “phlegm and blood stasis lurking in the collaterals with stasis transforming into toxin”, and advocates timely use of stasis-resolving and detoxifying therapy on the premise of protecting spleen-stomach function so as to delay pathological progression. Based on Professor XIE’s published experience as well as recent clinical and experimental studies on CAG, this paper systematically summarizes his understanding of pathogenesis, therapeutic strategy, medication characteristics and academic significance, aiming to provide reference for the inheritance of famous physicians’ experience and for the clinical prevention and treatment of CAG.
文章引用:徐懿杨, 梁国英. 谢晶日辨治慢性萎缩性胃炎经验[J]. 临床个性化医学, 2026, 5(4): 61-69. https://doi.org/10.12677/jcpm.2026.54225

参考文献

[1] 中华医学会消化病学分会, 中华医学会消化病学分会消化系统肿瘤协作组. 中国慢性胃炎诊治指南(2022年, 上海) [J]. 中华消化杂志, 2023, 43(3): 145-175.
[2] 王铭钧, 谷松, 朱辉, 等. 慢性萎缩性胃炎中医诊疗思路与方法[J/OL]. 辽宁中医杂志, 1-6.
https://link.cnki.net/urlid/21.1128.R.20260114.1111.012, 2026-07-28.
[3] 贾艮林, 梁国英, 单葳葳, 等. 谢晶日教授治疗慢性萎缩性胃炎伴肠化经验浅析[J]. 中国中西医结合消化杂志, 2020, 28(1): 66-68.
[4] 臧春雪, 谢晶日, 刘金狄. 谢晶日教授巧用对药治疗胃痛的临证经验[J]. 中国中西医结合消化杂志, 2018, 26(1): 95-98.
[5] 刘朝霞, 孟琦, 李贺薇, 等. 谢晶日辨治慢性萎缩性胃炎经验[J]. 辽宁中医杂志, 2021, 48(7): 31-33.
[6] 饶显俊, 谢晶日, 孙志文, 等. 谢晶日以“补土消积”疗法治疗慢性萎缩性胃炎伴低级别上皮内瘤变经验[J]. 陕西中医, 2023, 44(2): 233-236.
[7] 王海强, 吴思雨, 郑丽红, 等. 谢晶日基于因机论治对慢性萎缩性胃炎的药对选用[J]. 辽宁中医杂志, 2024, 51(2): 39-42.
[8] 顾冰燕, 钦丹萍, 杨新艳, 等. 健脾解毒方治疗木村-竹本闭合型萎缩性胃炎脾虚湿热证的随机对照试验——基于OLGA和OLGIM的疗效评价[J]. 中医杂志, 2026, 67(6): 648-656.
[9] 刘善敏, 刘萍, 邓芬, 等. 石斛消萎汤联合标准四联疗法治疗慢性萎缩性胃炎伴肠上皮化生临床研究[J]. 山东中医杂志, 2026, 45(2): 161-167.
[10] 邵晓雪, 刘若男, 王霜佳, 等. “健脾疏肝调神法”针灸治疗慢性萎缩性胃炎伴肠上皮化生[J]. 山东中医杂志, 2026, 45(3): 323-327, 334.
[11] 杨晓璇, 樊吟秋, 白甫江, 等. 基于真实世界的电针治疗慢性萎缩性胃炎临床疗效分析[J]. 中医药信息, 2026, 43(5): 60-66.
[12] 赵艳, 王新爱, 刘云, 等. 化浊通清饮联合针刺对慢性萎缩性胃炎患者的疗效研究[J]. 辽宁中医杂志, 2026, 53(1): 157-160.
[13] 李萌, 罗楠, 易柳凤, 等. 基于HOXA-AS3/miR-29a-3p/LTβR/NF-κB轴探讨健脾通络解毒方改善慢性萎缩性胃炎作用机制[J/OL]. 中国中医药信息杂志, 1-9.
https://doi.org/10.19879/j.cnki.1005-5304.202601453, 2026-07-28.
[14] 杜朋丽, 郭榆西, 王艺灿, 等. 香连化浊方调控GP73/PERK/ATF4信号通路影响内质网应激改善慢性萎缩性胃炎的机制[J/OL]. 中国实验方剂学杂志: 1-12.
https://www.chndoi.org/Resolution/Handler?doi=10.13422/j.cnki.syfjx.20260538, 2026-03-24.
[15] 何友成, 徐欣悦, 林诗锦, 等. 基于Toll样受体4与Sonic Hedgehog信号通路Crosstalk调控NLRP3/Caspase-1介导细胞焦亡探讨复方胃炎合剂治疗CAG的机制[J/OL]. 中国实验方剂学杂志, 1-10.
https://doi.org/10.13422/j.cnki.syfjx.20260316, 2026-07-28.
[16] 林洁, 徐婷婷, 冯婉思, 等. 基于NF-κB信号通路探讨金不换健胃解毒汤减轻慢性萎缩性胃炎模型大鼠胃黏膜损伤的作用机制[J/OL]. 中医学报, 1-12.
https://link.cnki.net/urlid/41.1411.R.20260302.1222.051, 2026-07-28.
[17] 于慧敏, 李滢滢, 王小杰, 等. 化瘀解毒方对慢性萎缩性胃炎大鼠的保护作用及机制[J]. 中国病理生理杂志, 2026, 42(2): 328-340.
[18] 马远新, 王健. 基于TGF-β1/PI3K/Akt信号通路探讨茯苓饮对慢性萎缩性胃炎大鼠胃组织损伤的影响[J]. 中成药, 2026, 48(2): 627-631.
[19] 张睿, 范静怡, 刘天颖, 等. 基于“肠道菌群-铁死亡”轴探讨四君子汤治疗慢性萎缩性胃炎的作用机制[J]. 中国中药杂志, 2026, 51(12): 3572-3580.